| A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus (NCT01466725) | Celgene | 2011-11-01 |
| A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma (NCT01380236) | Syntara | 2011-11-01 |
| Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease (NCT01323699) | Michael E. DeBakey VA Medical Center | 2011-11-01 |
| Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE- (NCT01360320) | Martin-Luther-Universität Halle-Wittenberg | 2011-11-01 |
| A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia (NCT01486784) | Abramson Cancer Center at Penn Medicine | 2011-11-01 |
| Effects of Intensive cART During Acute/Early HIV Infection (NCT01154673) | University of Toronto | 2011-11-01 |
| HIPEC for Peritoneal Carcinomatosis (NCT02040142) | Albert Einstein College of Medicine | 2011-11-01 |
| Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects (NCT01459419) | Inspira Medical AB | 2011-11-01 |
| Pazopanib in Relapsed and Refractory Small Cell Lung Cancer (NCT01713296) | Hellenic Oncology Research Group | 2011-11-01 |
| Niacin on Immune Activation : a Proof-of-concept Study (NCT02018965) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2011-11-01 |
| Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas (NCT01744249) | Grupo Espanol de Tumores Neuroendocrinos | 2011-11-01 |
| Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia (NCT01928823) | Charite University, Berlin, Germany | 2011-11-01 |
| PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine (NCT01441765) | Beth Israel Deaconess Medical Center | 2011-11-01 |
| Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer (NCT01488552) | Pancreatic Cancer Research Team | 2011-11-01 |
| A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic Syndrome (NCT01513317) | Janssen Research & Development, LLC | 2011-11-01 |
| Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of Sclerocorneal Limbus Amplified ex Vivo (NCT01470573) | Fundacion Clinic per a la Recerca Biomédica | 2011-11-01 |
| A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (NCT01481051) | Mati Therapeutics Inc. | 2011-11-01 |
| Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer (NCT01667211) | Chinese Academy of Medical Sciences | 2011-11-01 |
| A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis (NCT01447017) | DermaGen AB | 2011-11-01 |
| Treatment Study for Rural Latino Youth With Anxiety (NCT01491880) | University of California, San Diego | 2011-11-01 |
| Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission (NCT01465386) | Fred Hutchinson Cancer Center | 2011-11-01 |
| The Cooling And Surviving Septic Shock Study (CASS) (NCT01455116) | Danish Procalcitonin Study Group | 2011-11-01 |
| Efficacy of a Novel Multivitamin-Mineral Supplement in Preventing Vitamin Deficiency in Postoperative Bariatric Patients (NCT01475617) | Yasoo Health | 2011-11-01 |
| Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant (NCT01473810) | Oslo University Hospital | 2011-11-01 |
| Influence of Exercise on Anemia in MDS Patients (NCT01783249) | University of Rochester | 2011-11-01 |
| Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris (NCT01461655) | LEO Pharma | 2011-11-01 |
| Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency (NCT01450930) | Bruno Allolio | 2011-11-01 |
| Rotating Pazopanib and Everolimus to Avoid Resistance (NCT01408004) | Netherlands Working Group on Immunotherapy of Oncology | 2011-11-01 |
| ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma (NCT01481194) | Vejle Hospital | 2011-11-01 |
| Hearing Preservation Using Dexamethasone and Hyaluronic Acid for Cochlear Implantation (NCT01588925) | University of Sao Paulo General Hospital | 2011-11-01 |
| Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis (NCT01473797) | Assistance Publique - Hôpitaux de Paris | 2011-11-01 |
| Donepezil Trial for Motor Recovery in Acute Stroke (NCT01442766) | Imperial College London | 2011-11-01 |
| High Frequency Oscillatory Ventilation for Acute Respiratory Distress Syndrome (ARDS) (NCT01478802) | University of Athens | 2011-11-01 |
| Study of DA-9801 to Treat Diabetic Neuropathic Pain (NCT01813799) | Dong-A ST Co., Ltd. | 2011-11-01 |
| Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI (NCT01433016) | Meridian Bioscience, Inc. | 2011-11-01 |
| Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma (NCT01435369) | Medivation, Inc. | 2011-11-01 |
| Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients (NCT01461915) | Jazz Pharmaceuticals | 2011-11-01 |
| A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma (NCT01474239) | Hoffmann-La Roche | 2011-11-01 |
| Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema (NCT01476449) | Retina Vitreous Associates of Florida | 2011-11-01 |
| GENESIS Feasibility Study of the BARD Over-the-Wire Mesh Ablation System for the Treatment of Paroxysmal Atrial Fibrillation (NCT01430949) | C. R. Bard | 2011-11-01 |
| A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (NCT01481077) | Mati Therapeutics Inc. | 2011-11-01 |
| Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias (NCT01385592) | Novartis Pharmaceuticals | 2011-11-01 |
| Amniotic Membrane Graft In Syntomathic Bullous Keratopathy (NCT01926535) | Universidad de Valparaiso | 2011-11-01 |
| Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders (NCT01395953) | Massachusetts General Hospital | 2011-11-01 |
| Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With DLBCL: a Phase II Multicenter Study of the FIL (NCT01990144) | Fondazione Italiana Linfomi - ETS | 2011-11-01 |
| S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) (NCT01533324) | Second Military Medical University | 2011-11-01 |
| Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation (NCT01474551) | Memorial Sloan Kettering Cancer Center | 2011-11-01 |
| Efficacy and Safety of Kochujang Pills on Blood Lipids Profiles in Hyperlipidemia Subjects (NCT01865370) | Chonbuk National University Hospital | 2011-11-01 |
| Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer (NCT01483586) | KangLaiTe USA | 2011-11-01 |
| A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia (NCT01539616) | Zydus Lifesciences Limited | 2011-11-01 |
| A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer (NCT01379534) | Novartis Pharmaceuticals | 2011-11-01 |
| A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma (NCT01472198) | Gilead Sciences | 2011-11-01 |
| Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention (NCT01455935) | Jacobs Neurological Institute | 2011-11-01 |
| STRETCH OF RESPIRATORY MUSCLES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (NCT02036762) | University of Sao Paulo | 2011-11-01 |
| Perioperative Use of Desmopressin (DDAVP) in Breast Cancer (NCT01606072) | Laboratorio Elea Phoenix S.A. | 2011-11-01 |
| Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide (NCT01432600) | H. Lee Moffitt Cancer Center and Research Institute | 2011-11-01 |
| Compassionate Use of an Intravenous Fish Oil Emulsion in Infants With Cholestasis (NCT01601652) | Arthur J De Lorimier | 2011-11-01 |
| A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women (NCT01388491) | Teva Branded Pharmaceutical Products R&D, Inc. | 2011-10-31 |
| Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma (NCT01383928) | Millennium Pharmaceuticals, Inc. | 2011-10-31 |
| Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E (NCT01586195) | Genentech, Inc. | 2011-10-31 |
| Drug-drug Interaction Study (NCT01380743) | Amicus Therapeutics | 2011-10-31 |
| SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver (NCT01473004) | Thomas Jefferson University | 2011-10-31 |
| A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE) (NCT01414205) | Genentech, Inc. | 2011-10-31 |
| Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT (NCT00885456) | Marilyn MacKay-Lyons | 2011-10-30 |
| Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer (NCT01385059) | City of Hope Medical Center | 2011-10-28 |
| Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance (NCT01463670) | Memorial Sloan Kettering Cancer Center | 2011-10-28 |
| A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma (NCT01425996) | Taiwan Liposome Company | 2011-10-27 |
| Providing Access to Cord Blood Units for Transplants (NCT01479582) | National Cancer Institute (NCI) | 2011-10-27 |
| A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD) (NCT01462292) | GlaxoSmithKline | 2011-10-26 |
| Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery (NCT01468896) | National Cancer Institute (NCI) | 2011-10-26 |
| A Study of Axitinib in Advanced Carcinoid Tumors (NCT01435122) | H. Lee Moffitt Cancer Center and Research Institute | 2011-10-25 |
| Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030) (NCT01405924) | Merck Sharp & Dohme LLC | 2011-10-25 |
| Tecemotide (L-BLP25) in Prostate Cancer (NCT01496131) | EMD Serono | 2011-10-24 |
| A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100 (NCT01534052) | Astellas Pharma Inc | 2011-10-21 |
| Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma (NCT01393717) | City of Hope Medical Center | 2011-10-20 |
| Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell Lymphoma (NCT04484506) | Peking University | 2011-10-20 |
| Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer (NCT01471964) | Fox Chase Cancer Center | 2011-10-20 |
| A Trial of Triamcinolone With a GnRH Analog for Castration Resistant Prostate Cancer (NCT07161778) | Barts & The London NHS Trust | 2011-10-19 |
| A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma (NCT01390948) | Hoffmann-La Roche | 2011-10-18 |
| Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection (NCT01587586) | PharmaEssentia | 2011-10-18 |
| Hippocampal-Avoiding Whole Brain Irradiation With Simultaneous Integrated Boost for Treatment of Brain Metastases (NCT01414738) | University of Texas Southwestern Medical Center | 2011-10-18 |
| Preoperative Treatment With Cetuximab and/or IMC-A12 (NCT00957853) | M.D. Anderson Cancer Center | 2011-10-17 |
| Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies (NCT01416428) | Amgen | 2011-10-15 |
| Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) (NCT01453998) | GlaxoSmithKline | 2011-10-14 |
| The Effects of Ginseng on Cancer-Related Fatigue (NCT01375114) | M.D. Anderson Cancer Center | 2011-10-14 |
| Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer (NCT01554397) | University of California, San Diego | 2011-10-13 |
| A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma (NCT01460940) | Ohio State University Comprehensive Cancer Center | 2011-10-13 |
| A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2) (NCT01433991) | Eisai Inc. | 2011-10-13 |
| Liver Cell Transplant for Phenylketonuria (NCT01465100) | Ira Fox | 2011-10-12 |
| Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention (NCT01442792) | Bayer | 2011-10-12 |
| Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC (NCT01437605) | H. Lee Moffitt Cancer Center and Research Institute | 2011-10-11 |
| Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma (NCT01468311) | National Cancer Institute (NCI) | 2011-10-11 |
| Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma (NCT01601808) | University of Liverpool | 2011-10-10 |
| A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (NCT01387555) | Jennerex Biotherapeutics | 2011-10-08 |
| Open Label Study of Long Term Evaluation Against LDL-C Trial (NCT01439880) | Amgen | 2011-10-07 |
| Understanding Typhoid Disease After Vaccination (NCT01405521) | University of Oxford | 2011-10-07 |
| Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia (NCT01424982) | M.D. Anderson Cancer Center | 2011-10-05 |
| Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia (NCT01409161) | M.D. Anderson Cancer Center | 2011-10-05 |
| GSK2251052 in the Treatment of Complicated Intra-abdominal Infections (NCT01381562) | GlaxoSmithKline | 2011-10-03 |
| Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation (NCT01267812) | City of Hope Medical Center | 2011-10-03 |